Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel E Valdebenito

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Development (Cambridge, England)|July 18, 2025
In preprints: setting the tempo of developmentGabriel E Valdebenito, Margarete Diaz-Cuadros
The EMBO Journal|April 6, 2023
The mitochondrial ATP synthase as an ATP consumer-a surprising therapeutic targetGabriel E Valdebenito, Anitta R Chacko, Michael R Duchen
Trends in Cell Biology|November 27, 2021
Rewiring cell signalling pathways in pathogenic mtDNA mutationsChih-Yao Chung, Gabriel E Valdebenito, Anitta R Chacko, et al.
Autophagy|December 12, 2024
Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial functionChih-Yao Chung, Kritarth Singh, Preethi Sheshadri, et al.
Nature Communications|November 5, 2021
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutationChih-Yao Chung, Kritarth Singh, Vassilios N Kotiadis, et al.
Stem Cell Reports|March 14, 2025
Metabolic remodeling in hiPSC-derived myofibers carrying the m.3243A>G mutationGabriel E Valdebenito, Anitta R Chacko, Chih-Yao Chung, et al.
The Journal of Experimental Medicine|November 19, 2024
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiencyElena Blanco, Carme Camps, Sameer Bahal, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Development (Cambridge, England)|July 18, 2025
In preprints: setting the tempo of developmentGabriel E Valdebenito, Margarete Diaz-Cuadros
The EMBO Journal|April 6, 2023
The mitochondrial ATP synthase as an ATP consumer-a surprising therapeutic targetGabriel E Valdebenito, Anitta R Chacko, Michael R Duchen
Trends in Cell Biology|November 27, 2021
Rewiring cell signalling pathways in pathogenic mtDNA mutationsChih-Yao Chung, Gabriel E Valdebenito, Anitta R Chacko, et al.
Autophagy|December 12, 2024
Inhibition of the PI3K-AKT-MTORC1 axis reduces the burden of the m.3243A>G mtDNA mutation by promoting mitophagy and improving mitochondrial functionChih-Yao Chung, Kritarth Singh, Preethi Sheshadri, et al.
Nature Communications|November 5, 2021
Constitutive activation of the PI3K-Akt-mTORC1 pathway sustains the m.3243 A > G mtDNA mutationChih-Yao Chung, Kritarth Singh, Vassilios N Kotiadis, et al.
Stem Cell Reports|March 14, 2025
Metabolic remodeling in hiPSC-derived myofibers carrying the m.3243A>G mutationGabriel E Valdebenito, Anitta R Chacko, Chih-Yao Chung, et al.
The Journal of Experimental Medicine|November 19, 2024
Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiencyElena Blanco, Carme Camps, Sameer Bahal, et al.
Pageof 1